% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sichero:286587,
author = {L. Sichero and M. G. Gonçalves and F. Bettoni and E. M.
Coser and G. Mota and R. A. L. Nunes and A. M. d. C.
Mercante and R. Natalino and M. Uno and M. J. Ferreira Alves
and L. L. Matos and L. P. Kowalski and M. A. V. Kulcsar and
G. F. de Alvarenga and D. Höfler$^*$ and L. Schroeder$^*$
and T. Waterboer$^*$ and M. Tommasino and L. L. Villa},
title = {{D}etection of serum biomarkers of {HPV}-16 driven
oropharynx and oral cavity cancer in {B}razil.},
journal = {Oral oncology},
volume = {149},
issn = {0964-1955},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DKFZ-2023-02804},
pages = {106676},
year = {2024},
note = {Volume 149, February 2024, 106676},
abstract = {HPV-16 driven oropharynx/oral cavity squamous cell
carcinomas prevalence varies globally. We evaluated the
presence of HPV-16 ctDNA and HPV-16 E6 antibodies in samples
obtained from participants treated at the Instituto do
Cancer do Estado de Sao Paulo, ICESP, and from whom tumoral
HPV DNA, HPV-16 E6*I mRNA, and p16INK4a status was also
accessed.HPV was genotyped by PCR-hybridization. All HPV DNA
positive and ∼10 $\%$ HPV DNA negative cases underwent
p16INK4a immunohistochemistry and E6*I RNA testing using a
multiplex bead based protocol. HPV-16 ctDNA and anti-E6
antibodies were assessed by ddPCR (digital droplet PCR) and
multiplex serology, respectively.The prevalence of HPV-16 in
oropharynx carcinoma (OPC) cases was low (8.7 $\%)$ when
considering solely HPV-16 DNA detection, and even lower (5.2
$\%)$ when taken into consideration the concomitant
detection of HPV-16 E6*I RNA and/or p16INK4 (HPV-16
attributable fraction - AF). None of the oral cavity cancer
(OCC) cases were detected with HPV-16 DNA. HPV-16 ctDNA was
more commonly detected than HPV-16 E6 antibodies (29.8 $\%$
versus 10.6 $\%).$ Both serum biomarkers attained 100 $\%$
sensitivity of detecting HPV-16 AF OPC, however the
specificity of the HPV-16 anti-E6 biomarker was higher
compared to ctDNA (93.2 $\%$ versus 75.0 $\%).$ Finally,
when both HPV-16 ctDNA and anti-E6 biomarkers were
considered together, the sensitivity and specificity for
HPV-16 OPC detection was 100 $\%$ and about 70 $\%,$
respectively, independently of analyzing HPV-16 DNA positive
or HPV-16 AF tumors.Our findings corroborate that serum
biomarkers are highly sensitive and specific biomarkers for
detection of HPV-associated OPC.},
keywords = {Antibodies (Other) / HPV ctDNA (Other) / Head and neck
cancer (Other) / Human papillomavirus (Other) / Serum
biomarkers (Other)},
cin = {F020},
ddc = {610},
cid = {I:(DE-He78)F020-20160331},
pnm = {316 - Infektionen, Entzündung und Krebs (POF4-316)},
pid = {G:(DE-HGF)POF4-316},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38150987},
doi = {10.1016/j.oraloncology.2023.106676},
url = {https://inrepo02.dkfz.de/record/286587},
}